Torsion dystonias and other involuntary movements (Formulary)

MHRA advice: Botulinum toxin products: rare but serious risks (December 2014) (www.gov.uk).

BOTULINUM TOXIN TYPE A - (First line)

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Powder for solution for injection vial 50 units, 100 units (Xeomin®) (s)

Important: Formulation and dosage details

Formulation:

Powder for solution for injection vial 50 units, 100 units (Botox®) (s)

Important: Formulation and dosage details

Formulation:

Powder for solution for injection vial 300 units, 500 units (Dysport®) (s)

Editorial Information

Document Id: F099